Reprogramming tumor microenvironment of pancreatic cancer by CAF-targeted sonodynamic therapy combined with chemotherapy
Source abstract
Abstract
Pancreatic cancer is among the most aggressive malignancies, showing poor responses to conventional chemotherapy. Sonodynamic therapy (SDT) has emerged as a promising treatment. However, cancer-associated fibroblasts (CAFs) restrict SDT efficacy and contribute to poor therapeutic response. To overcome this barrier, we developed a CAF-targeted SDT–chemotherapy system to remodel the drug-resistant tumor microenvironment and enhance therapeutic outcomes. Using the GSE212966 dataset, Fibronectin (Fn) was identified as the therapeutic target in CAFs. We then constructed FnBPA5-IR-CF3@Dox, a nano micelle integrating CAF targeting, SDT, and doxorubicin (Dox) delivery. The system exhibited high drug loading capacity, good dispersion, stability, and selective accumulation in CAFs. In multicellular tumor spheroids and orthotopic pancreatic cancer mouse models, FnBPA5-IR-CF3@Dox + US treatment achieved significant antitumor efficacy by selectively eliminating CAFs, inhibiting stromal proliferation, reducing interstitial fluid pressure, enhancing intratumoral drug penetration. This CAF-targeted SDT-chemotherapy strategy markedly improved chemotherapy effectiveness and suppressed tumor growth. In conclusion, our study demonstrates that CAF-targeted SDT combined with chemotherapy provides an effective approach for reprogramming the tumor microenvironment and offers a promising therapeutic avenue for pancreatic cancer treatment. • CAF-targeted FnBPA5-IR-CF3@Dox integrates CAF targeting, SDT, and doxorubicin delivery. • FnBPA5-IR-CF3@Dox combined with US improves chemotherapy efficacy and suppresses tumor growth. • FnBPA5-IR-CF3@Dox combined with US selectively eliminates CAFs, inhibits stromal proliferation, lowers interstitial fluid pressure, and enhances intratumoral drug penetration.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Ultrasound and Hyperthermia Applications · Nanoplatforms for cancer theranostics · Cancer Research and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (42)
Show source-provided references
1. Biomimetic nanosystems for pancreatic cancer therapy: a review10.1016/j.jconrel.2025.113824 ↗
2. Pancreatic cancer: advances and challenges10.1016/j.cell.2023.02.014 ↗
3. Pancreatic ductal adenocarcinoma: the latest on diagnosis, molecular profiling, and systemic treatments10.3389/fonc.2024.1386699 ↗
4. Cancer statistics, 2023
5. Cancer-associated fibroblasts in pancreatic cancer: new subtypes, new markers, new targets10.1002/path.5926 ↗
6. Fibroblasts in pancreatic cancer: molecular and clinical perspectives10.1016/j.molmed.2023.03.002 ↗
7. Fibroblasts in cancer10.1038/nrc1877 ↗
8. Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma therapy: Challenges and opportunities10.1016/j.canlet.2024.216859 ↗
9. Normal fibroblasts induce E-cadherin loss and increase lymph node metastasis in gastric cancer
10. Pancreatic cancer: pathogenesis, screening, diagnosis, and treatment10.1053/j.gastro.2022.03.056 ↗
11. Heterogeneity and plasticity of cancer-associated fibroblasts in the pancreatic tumor microenvironment10.1016/j.semcancer.2021.03.006 ↗
12. Fibroblasts induced epithelial to mesenchymal transition of tumor cells and their extra circulation traveling behavior10.1016/j.mehy.2016.01.017 ↗
13. Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept10.1186/s13046-023-02935-3 ↗
14. ECM-Targeting bacteria enhance chemotherapeutic drug efficacy by lowering IFP in tumor mouse models10.1016/j.jconrel.2023.02.001 ↗
15. Mounting pressure in the microenvironment: Fluids, solids, and cells in pancreatic ductal adenocarcinoma10.1053/j.gastro.2016.03.040 ↗
16. Ultrasound activated probe for disease imaging and therapy In-Vivo10.1016/j.addr.2023.115158 ↗
17. Hypoxia-Adapted sono-chemodynamic treatment of orthotopic pancreatic carcinoma using copper metal-organic frameworks loaded with an ultrasound-induced free radical initiator10.1021/acsami.1c11017 ↗
18. Recent advances in drug delivery and targeting for the treatment of pancreatic cancer10.1016/j.jconrel.2023.12.053 ↗
19. Cancer-associated fibroblasts in the single-cell era10.1038/s43018-022-00411-z ↗
20. Interrogation of the tumor microenvironment by nanoparticles10.1016/j.canlet.2025.217454 ↗
21. Mechanically stressed cancer microenvironment: role in pancreatic cancer progression
22. In vivo fluorescent labeling and tracking of extracellular matrix10.1038/s41596-023-00867-y ↗
23. Fibronectin fibers are highly tensed in healthy organs in contrast to tumors and virus-infected lymph nodes
24. Enhancement of antitumor immunotherapy using mitochondria-targeted cancer cell membrane-biomimetic MOF-mediated sonodynamic therapy and checkpoint blockade immunotherapy10.1186/s12951-022-01453-2 ↗
25. A novel near-infrared trifluoromethyl heptamethine cyanine dye with mitochondria-targeting for integration of collaborative treatment of photothermal and sonodynamic therapy10.1016/j.mtadv.2022.100251 ↗
26. Low-Intensity Focused Ultrasound Produces Immune Response in Pancreatic Cancer10.1016/j.ultrasmedbio.2022.06.017 ↗
27. Organic sonosensitizers for sonodynamic therapy: from small molecules and nanoparticles toward clinical development
28. Comprehensive integration of single-cell data10.1016/j.cell.2019.05.031 ↗
29. Dimensionality reduction for visualizing single-cell data using UMAP
30. Phenotype molding of stromal cells in the lung tumor microenvironment10.1038/s41591-018-0096-5 ↗
31. Integrating single-cell transcriptomic data across different conditions, technologies, and species10.1038/nbt.4096 ↗
32. TGF-beta1-activated cancer-associated fibroblasts promote breast cancer invasion, metastasis and epithelial-mesenchymal transition by autophagy or overexpression of FAP-alpha10.1016/j.bcp.2021.114527 ↗
33. Multicellular Tumor spheroids (MCTS) as a 3D in vitro evaluation tool of nanoparticles10.1002/smll.201702858 ↗
34. Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma10.1016/j.ccr.2012.01.007 ↗
35. Active immunisation of black tiger prawn (Penaeus monodon) against vibriosis in Thailand
36. Mitochondrial membrane potential acts as a retrograde signal to regulate cell cycle progression10.26508/lsa.202302091 ↗
37. Three-dimensional culture systems in cancer research: focus on tumor spheroid model10.1016/j.pharmthera.2016.03.013 ↗
38. Light-assisted hierarchical intratumoral penetration and programmed antitumor therapy based on tumor microenvironment (TME)-amendatory and self-adaptive polymeric nanoclusters10.1016/j.biomaterials.2020.120166 ↗
39. High interstitial fluid pressure - an obstacle in cancer therapy10.1038/nrc1456 ↗
40. A practical distribution pattern of alpha-SMA-positive carcinoma associated fibroblasts indicates poor prognosis of patients with pancreatic ductal adenocarcinoma10.1016/j.tranon.2025.102282 ↗
41. Targeting cancer-associated fibroblast-driven LIF/LIFR axis improves the therapeutic efficacy of gemcitabine and nab-paclitaxel in pancreatic cancer10.1038/s41698-025-01046-w ↗
42. Cancer-Associated fibroblasts: from spectators to protagonists in pancreatic cancer progression10.1158/0008-5472.CAN-24-2448 ↗